Deep phenotyping of an international series of patients with late‐onset dysferlinopathy

To describe the clinical, pathological, and molecular characteristics of late‐onset (LO) dysferlinopathy patients.

[1]  Y. Hong,et al.  Null variants in DYSF result in earlier symptom onset , 2020, Clinical genetics.

[2]  G. Comi,et al.  New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy. , 2020, Brain : a journal of neurology.

[3]  T. Niihori,et al.  The genetic profile of dysferlinopathy in a cohort of 209 cases: Genotype–phenotype relationship and a hotspot on the inner DysF domain , 2020, Human mutation.

[4]  S. Thoms,et al.  Functions of Vertebrate Ferlins , 2020, Cells.

[5]  Christopher A. Lazarski,et al.  Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B , 2019, Nature Communications.

[6]  H. Goebel,et al.  1st ENMC European meeting: The EURO-NMD pathology working group Recommended Standards for Muscle Pathology Amsterdam, The Netherlands, 7 December 2018 , 2019, Neuromuscular Disorders.

[7]  J. Matsumoto,et al.  Camptocormia: Etiology, diagnosis, and treatment response , 2018 .

[8]  H. Otero,et al.  Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  J. Jaiswal,et al.  Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle , 2017, Human molecular genetics.

[10]  C. Angelini,et al.  Progress and challenges in diagnosis of dysferlinopathy , 2016, Muscle & nerve.

[11]  J. Bevilacqua,et al.  Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies , 2016, Experimental Neurology.

[12]  T. Hortobágyi,et al.  Late onset dysferlinopathy mimicking treatment resistant polymyositis. , 2016, Joint, bone, spine : revue du rhumatisme.

[13]  M. Milone,et al.  Camptocormia as presenting manifestation of a spectrum of myopathic disorders , 2015, Muscle & nerve.

[14]  C. Spurney,et al.  Inhibition of inflammation with celastrol fails to improve muscle function in dysferlin-deficient A/J mice , 2015, Journal of the Neurological Sciences.

[15]  Guixiu Shi,et al.  Late-onset dysferlinopathy presented as "liver enzyme" abnormalities: a technical note. , 2014, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[16]  Y. Itoyama,et al.  Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  T. Partridge,et al.  Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response , 2012, Neuromuscular Disorders.

[18]  S. M. van der Maarel,et al.  Comparison of Dysferlin Expression in Human Skeletal Muscle with That in Monocytes for the Diagnosis of Dysferlin Myopathy , 2011, PloS one.

[19]  C. Angelini,et al.  Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis , 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[20]  P. Cintas,et al.  Bent spine syndrome (camptocormia): a retrospective study of 63 patients. , 2010, Joint, bone, spine : revue du rhumatisme.

[21]  C. Béroud,et al.  Analysis of the DYSF mutational spectrum in a large cohort of patients , 2009, Human mutation.

[22]  K. Bushby,et al.  Late onset in dysferlinopathy widens the clinical spectrum , 2008, Neuromuscular Disorders.

[23]  T. Maisonobe,et al.  Complete fatty degeneration of lumbar erector spinae muscles caused by a primary dysferlinopathy , 2008, Muscle & nerve.

[24]  D. Figarella-Branger,et al.  Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. , 2007, Archives of neurology.

[25]  J. T. Dunnen,et al.  AHNAK a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  N. Bresolin,et al.  Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies , 2005, Human mutation.

[27]  I. Nonaka,et al.  Dysferlinopathy associated with rigid spine syndrome , 2004, Neuropathology : official journal of the Japanese Society of Neuropathology.

[28]  Y. Itoyama,et al.  Novel dysferlin mutations and characteristic muscle atrophy in late‐onset Miyoshi myopathy , 2004, Muscle & nerve.

[29]  T. Rando,et al.  Late‐onset distal muscular dystrophy affecting the posterior calves , 2003, Muscle & nerve.

[30]  J. Beckmann,et al.  Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy , 2001, Neurology.

[31]  K. Bushby,et al.  Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations , 2001, Neuromuscular Disorders.

[32]  M. Baiget,et al.  Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype , 2001, Annals of neurology.

[33]  K. Bushby,et al.  The third human FER-1-like protein is highly similar to dysferlin. , 2000, Genomics.

[34]  Pieter J. de Jong,et al.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy , 1998, Nature Genetics.

[35]  J. Beckmann,et al.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B , 1998, Nature Genetics.

[36]  R. Waterston,et al.  Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. , 1988, The New England journal of medicine.

[37]  K. Bushby,et al.  The clinical outcome study for dysferlinopathy : An international multicenter study , 2019 .

[38]  J. Vissing,et al.  Axial myopathy: an overlooked feature of muscle diseases. , 2016, Brain : a journal of neurology.

[39]  Y. Itoyama,et al.  Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2 B , 2012 .

[40]  A. Pestronk,et al.  Assessment of disease progression in dysferlinopathy A 1-year cohort study , 2022 .